GALAPAGOS NV |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.74 EUR | +1.82% |
|
+1.90% | -30.41% |
| May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
| May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 26.42 | 31.94 | 30.37 |
| Spread/Res. | -2.57% | -19.41% | -15.25% |
| Spread/Supp. | +3.29% | +3.29% | +1.90% |
| Support | 24.92 | 24.92 | 25.26 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GLPG Stock
- Charts Galapagos NV
